However, given the complex nature of MS, blocking one or more cytokines is usually insufficient, and inhibiting signaling pathways, such as the NF-κB pathway, might cause severe complications because these pathways are essential for preserving normal cellular functions. This evidence concerns the gene NFKB1 and myeloid sarcoma.